Show simple item record

dc.contributor.authorFreire, Marina de Borba Oliveirapt_BR
dc.contributor.authorSilva, Bruna Gonçalves Cordeiro dapt_BR
dc.contributor.authorBertoldi, Andréa Dâmasopt_BR
dc.contributor.authorFontanella, Andréia Turminapt_BR
dc.contributor.authorMengue, Sotero Serratept_BR
dc.contributor.authorRamos, Luiz Robertopt_BR
dc.contributor.authorTavares, Noemia Urruth Leãopt_BR
dc.contributor.authorDal Pizzol, Tatiane da Silvapt_BR
dc.contributor.authorArrais, Paulo Sérgio Douradopt_BR
dc.contributor.authorFarias, Mareni Rochapt_BR
dc.contributor.authorLuiza, Vera Lúciapt_BR
dc.contributor.authorOliveira, Maria Auxiliadorapt_BR
dc.contributor.authorMenezes, Ana Maria Baptistapt_BR
dc.date.accessioned2022-10-03T04:48:35Zpt_BR
dc.date.issued2022pt_BR
dc.identifier.issn0034-8910pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/249545pt_BR
dc.description.abstractOBJECTIVE: To evaluate the utilization of benzodiazepines (BZD) in Brazilian older adults, based on the Pesquisa Nacional de Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM - National Survey of Access, Use and Promotion of Rational Use of Medicines). METHODS: The PNAUM is a cross-sectional study conducted between 2013 and 2014, representing the Brazilian urban population. In the present study, we included 60 years or older (n = 9,019) individuals. We calculated the prevalence of BZD utilization in the 15 days prior to survey data collection according to independent variables, using a hierarchical Poisson regression model. A semistructured interview performed empirical data collection (household interview). RESULTS: The prevalence of BZD utilization in the older adults was 9.3% (95%CI: 8.3–10.4). After adjustments, BZD utilization was associated with female sex (PR = 1.88; 95%CI: 1.52–2.32), depression (PR = 5.31; 95%CI: 4.41–6, 38), multimorbidity (PR = 1.44; 95%CI: 1.20–1.73), emergency room visit or hospitalization in the last 12 months (PR = 1.42; 95%CI: 1.18–1.70 ), polypharmacy (PR = 1.26; 95%CI: 1.01–1.57) and poor or very poor self-rated health (PR = 4.16; 95%CI: 2.10–8.22). Utilization was lower in the North region (PR = 0.18; 95%CI: 0.13–0.27) and in individuals who reported abusive alcohol consumption in the last month (PR = 0.42; 95%CI: 0.19–0.94). CONCLUSION: Despite contraindications, results showed a high prevalence of BZD utilization in older adults, particularly in those with depression, and wide regional and sex differences.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofRevista de saúde pública. Vol. 56 (2022), 10, 13 p.pt_BR
dc.rightsOpen Accessen
dc.subjectBenzodiazepinas : Uso terapêutico : Idosospt_BR
dc.subjectAgeden
dc.subjectDrug utilizationen
dc.subjectUso de medicamentos : Brasilpt_BR
dc.subjectBenzodiazepinesen
dc.subjectEstudos transversaispt_BR
dc.subjectRisk factorsen
dc.subjectCross-sectional studiesen
dc.titleBenzodiazepines utilization in Brazilian older adults : a population-based studypt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001138464pt_BR
dc.type.originNacionalpt_BR


Files in this item

Thumbnail
   

This item is licensed under a Creative Commons License

Show simple item record